SCHEMBL25955392

SCHEMBL25955392

CC[N+](C)(CC)CCCNc1cccc2c1C(=O)c1c(N)ccc(N)c1C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 7/20 0.51
▸ FGB P02675 2/20 0.47
▸ NSD2 O96028 1/20 0.47
▸ MMP14 P50281 1/20 0.47
▸ KMT2A Q03164 7/20 0.44
▸ MEN1 O00255 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ POLB P06746 5/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ EGFR P00533 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ RAD52 P43351 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ BLM P54132 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ ADORA2A P29274 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20333884 0.85 FGB (0.53) TERTFGBNSD2MMP14KMT2A
SCHEMBL13226281 0.84 ADORA2A (0.40) TERTFGBNSD2MMP14KMT2A
SCHEMBL23787833 0.83 CYP1A2 (0.52) TERTFGBNSD2MMP14KMT2A
SCHEMBL14452184 0.83 SMN1; SMN2 (0.49) TERTFGBNSD2MMP14KMT2A
SCHEMBL13226274 0.82 ADORA2A (0.43) TERTFGBNSD2MMP14KMT2A
SCHEMBL23616028 0.82 MEN1 (0.51) TERTFGBNSD2MMP14KMT2A
SCHEMBL7829735 0.81 NSD2 (0.55) TERTFGBNSD2MMP14KMT2A
SCHEMBL20333859 0.80 TERT (0.66) TERTFGBNSD2MMP14KMT2A
SCHEMBL13226269 0.79 TERT (0.50) TERTFGBNSD2MMP14KMT2A
SCHEMBL25937776 0.79 NSD2 (0.58) TERTFGBNSD2MMP14KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION KRT18, CUTA, KLK5 TERT 1382/4885FGB 247/4885NSD2 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback